Arming the Melanoma Sentinel Lymph Node through Local Administration of CpG-B and GM-CSF: Recruitment and Activation of BDCA3/CD141(+) Dendritic Cells and Enhanced Cross-Presentation

B.J.R. Sluijter; M.F.C.M. van den Hout; B.D. Koster; P.A.M. van Leeuwen; F.L. Schneiders; R. van de Ven; B.G. Molenkamp; S. Vosslamber; C.L. Verweij; M.P. van den Tol; A.J.M. van den Eertwegh; R.J. Scheper; T.D. de Gruijl

doi:10.1158/2326-6066.CIR-14-0165

Arming the Melanoma Sentinel Lymph Node through Local Administration of CpG-B and GM-CSF: Recruitment and Activation of BDCA3/CD141(+) Dendritic Cells and Enhanced Cross-Presentation

B.J.R. Sluijter, M.F.C.M. van den Hout, B.D. Koster, P.A.M. van Leeuwen, F.L. Schneiders, R. van de Ven, B.G. Molenkamp, S. Vosslamber, C.L. Verweij, M.P. van den Tol, A.J.M. van den Eertwegh, R.J. Scheper, T.D. de Gruijl

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	495-505
Journal	Cancer Immunology Research
Volume	3
Issue number	5
DOIs	https://doi.org/10.1158/2326-6066.CIR-14-0165
Publication status	Published - 2015

Access to Document

10.1158/2326-6066.CIR-14-0165

Cite this

Sluijter, B. J. R., van den Hout, M. F. C. M., Koster, B. D., van Leeuwen, P. A. M., Schneiders, F. L., van de Ven, R., Molenkamp, B. G., Vosslamber, S., Verweij, C. L., van den Tol, M. P., van den Eertwegh, A. J. M., Scheper, R. J., & de Gruijl, T. D. (2015). Arming the Melanoma Sentinel Lymph Node through Local Administration of CpG-B and GM-CSF: Recruitment and Activation of BDCA3/CD141(+) Dendritic Cells and Enhanced Cross-Presentation. Cancer Immunology Research, 3(5), 495-505. https://doi.org/10.1158/2326-6066.CIR-14-0165

@article{a5258f046ebe47998f5a25dfa9123893,

title = "Arming the Melanoma Sentinel Lymph Node through Local Administration of CpG-B and GM-CSF: Recruitment and Activation of BDCA3/CD141(+) Dendritic Cells and Enhanced Cross-Presentation",

author = "B.J.R. Sluijter and {van den Hout}, M.F.C.M. and B.D. Koster and {van Leeuwen}, P.A.M. and F.L. Schneiders and {van de Ven}, R. and B.G. Molenkamp and S. Vosslamber and C.L. Verweij and {van den Tol}, M.P. and {van den Eertwegh}, A.J.M. and R.J. Scheper and {de Gruijl}, T.D.",

year = "2015",

doi = "10.1158/2326-6066.CIR-14-0165",

language = "Undefined/Unknown",

volume = "3",

pages = "495--505",

journal = "Cancer Immunology Research",

issn = "2326-6066",

publisher = "American Association for Cancer Research Inc.",

number = "5",

}

Sluijter, BJR, van den Hout, MFCM, Koster, BD, van Leeuwen, PAM , Schneiders, FL , van de Ven, R, Molenkamp, BG, Vosslamber, S, Verweij, CL, van den Tol, MP , van den Eertwegh, AJM , Scheper, RJ & de Gruijl, TD 2015, 'Arming the Melanoma Sentinel Lymph Node through Local Administration of CpG-B and GM-CSF: Recruitment and Activation of BDCA3/CD141(+) Dendritic Cells and Enhanced Cross-Presentation', Cancer Immunology Research, vol. 3, no. 5, pp. 495-505. https://doi.org/10.1158/2326-6066.CIR-14-0165

Arming the Melanoma Sentinel Lymph Node through Local Administration of CpG-B and GM-CSF: Recruitment and Activation of BDCA3/CD141(+) Dendritic Cells and Enhanced Cross-Presentation. / Sluijter, B.J.R.; van den Hout, M.F.C.M.; Koster, B.D. et al.

In: Cancer Immunology Research, Vol. 3, No. 5, 2015, p. 495-505.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Arming the Melanoma Sentinel Lymph Node through Local Administration of CpG-B and GM-CSF: Recruitment and Activation of BDCA3/CD141(+) Dendritic Cells and Enhanced Cross-Presentation

AU - Sluijter, B.J.R.

AU - van den Hout, M.F.C.M.

AU - Koster, B.D.

AU - van Leeuwen, P.A.M.

AU - Schneiders, F.L.

AU - van de Ven, R.

AU - Molenkamp, B.G.

AU - Vosslamber, S.

AU - Verweij, C.L.

AU - van den Tol, M.P.

AU - van den Eertwegh, A.J.M.

AU - Scheper, R.J.

AU - de Gruijl, T.D.

PY - 2015

Y1 - 2015

U2 - 10.1158/2326-6066.CIR-14-0165

DO - 10.1158/2326-6066.CIR-14-0165

M3 - Article

C2 - 25633713

VL - 3

SP - 495

EP - 505

JO - Cancer Immunology Research

JF - Cancer Immunology Research

SN - 2326-6066

IS - 5

ER -